Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 4101653, 13 pages
https://doi.org/10.1155/2017/4101653
Research Article

Salinomycin Exerts Anticancer Effects on PC-3 Cells and PC-3-Derived Cancer Stem Cells In Vitro and In Vivo

1Clinical Research Institute, The Second Affiliated Hospital, University of South China, Hengyang 421001, China
2College of Nursing, Hunan Polytechnic of Environment and Biology, Hengyang 421005, China
3Department of Urology, The Second Affiliated Hospital, University of South China, Hengyang 421001, China
4Department of Urology, The First People’s Hospital of Yueyang, Yueyang 414000, China

Correspondence should be addressed to Yi Wang; moc.621@8010enyaw

Received 12 January 2017; Accepted 27 March 2017; Published 6 June 2017

Academic Editor: Anne Hamburger

Copyright © 2017 Yunsheng Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Zhang, Y. Zhang, X. Zhang, and B. Hong, “Prostaglandin-endoperoxide synthase 2 (PTGS2) rs20417 polymorphism and prostate cancer risk: a meta analysis,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 11, pp. 20454–20462, 2015. View at Google Scholar · View at Scopus
  2. M. Fraser, A. Berlin, R. G. Bristow, and T. Van der Kwast, “Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer,” Urologic Oncology: Seminars and Original Investigations, vol. 33, no. 2, pp. 85–94, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. J. B. Aragon-Ching and W. L. Dahut, “Novel androgen deprivation therapy (ADT) in the treatment of advanced prostate cancer,” Drug Discovery Today: Therapeutic Strategies, vol. 7, no. 1-2, pp. 31–35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. N. Martins and S. Gandy, “Prostate cancer: increased dementia risk following androgen deprivation therapy?” Nature Reviews Urology, vol. 13, no. 4, pp. 188-189, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. A. P. Rybak, R. G. Bristow, and A. Kapoor, “Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression,” Oncotarget, vol. 6, no. 4, pp. 1900–1919, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. M. F. Clarke, J. E. Dick, P. B. Dirks et al., “Cancer stem cells–perspectives on current status and future directions: AACR Workshop on cancer stem cells,” Cancer Research, vol. 66, no. 19, pp. 9339–9344, 2006. View at Google Scholar
  7. R. Hellsten, M. Johansson, A. Dahlman, O. Sterner, and A. Bjartell, “Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells,” PLoS ONE, vol. 6, no. 7, Article ID e22118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Jiang, J. Peng, Y. Zhang, W. C. S. Cho, and K. Jin, “The implications of cancer stem cells for cancer therapy,” International Journal of Molecular Sciences, vol. 13, no. 12, pp. 16636–16657, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-C. Wang, T.-K. Chao, C.-C. Chang, Y.-T. Yo, M.-H. Yu, and H.-C. Lai, “Drug screening identifies niclosamide as an inhibitor of breast cancer stem-like cells,” PLoS ONE, vol. 8, no. 9, Article ID e74538, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. P. B. Gupta, T. T. Onder, G. Jiang et al., “Identification of selective inhibitors of cancer stem cells by high-throughput screening,” Cell, vol. 138, no. 4, pp. 645–659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Managò, L. Leanza, L. Carraretto et al., “Early effects of the antineoplastic agent salinomycin on mitochondrial function,” Cell Death and Disease, Article ID e1930, 2015. View at Publisher · View at Google Scholar
  12. K.-Y. Kim, S.-N. Yu, S.-Y. Lee et al., “Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization,” Biochemical and Biophysical Research Communications, vol. 413, no. 1, pp. 80–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Lu and Y. Li, “Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells,” Journal of Cellular Biochemistry, vol. 115, no. 10, pp. 1799–1807, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Schenk, B. Aykut, C. Teske, N. A. Giese, J. Weitz, and T. Welsch, “Salinomycin inhibits growth of pancreatic cancer and cancer cell migration by disruption of actin stress fiber integrity,” Cancer Letters, vol. 358, no. 2, pp. 161–169, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. S.-H. Kim, Y.-J. Choi, K.-Y. Kim et al., “Salinomycin simultaneously induces apoptosis and autophagy through generation of reactive oxygen species in osteosarcoma U2OS cells,” Biochemical and Biophysical Research Communications, vol. 473, no. 2, pp. 607–613, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Liu, P.-C. Liu, R. Liu, and W. Xing, “Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry,” Medical Science Monitor Basic Research, vol. 21, pp. 15–20, 2015. View at Publisher · View at Google Scholar
  17. Y. Zhang, L. Yang, Y. Lin, Z. Rong, X. Liu, and D. Li, “SPATA12 and its possible role in DNA damage induced by ultraviolet-C,” PLoS ONE, vol. 8, no. 10, Article ID e78201, 2013. View at Google Scholar
  18. R. Guo, B. Liu, S. Zhou, B. Zhang, and Y. Xu, “The protective effect of fasudil on the structure and function of cardiac mitochondria from rats with type 2 diabetes induced by streptozotocin with a high-fat diet is mediated by the attenuation of oxidative stress,” BioMed Research International, vol. 2013, Article ID 430791, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Zhang, X. Wu, Y. Li et al., “Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis,” Scientific Reports, vol. 6, no. 1, Article ID 33787, 2016. View at Publisher · View at Google Scholar
  20. M. L. Lee, S. Y. Fung, I. Chung, J. Pailoor, S. H. Cheah, and N. H. Tan, “King cobra (Ophiophagus hannah) venom L-amino acid oxidase induces apoptosis in PC-3 cells and suppresses PC-3 solid tumor growth in a tumor xenograft mouse model,” International Journal of Medical Sciences, vol. 11, no. 6, pp. 593–601, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. H. An, J. Y. Kim, N. Lee, Y. Cho, E. Oh, and J. H. Seo, “Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway,” Biochemical and Biophysical Research Communications, vol. 466, no. 4, pp. 696–703, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Oktem, A. Bilir, R. Uslu et al., “Expression profiling of stem cell signaling alters with spheroid formation in CD133high/CD44high prostate cancer stem cells,” Oncology Letters, vol. 7, no. 6, pp. 2103–2109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Jaworska, W. Król, and E. Szliszka, “Prostate cancer stem cells: research advances,” International Journal of Molecular Sciences, vol. 16, no. 11, pp. 27433–27449, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. R. A. Taylor, R. Toivanen, and G. P. Risbridger, “Stem cells in prostate cancer: treating the root of the problem,” Endocrine-Related Cancer, vol. 17, no. 4, pp. R273–R285, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Zhou, P. Li, X. Xue et al., “Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species,” Toxicology Letters, vol. 222, no. 2, pp. 139–145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Mao, S. Fan, W. Ma et al., “Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment,” Cell Death & Disease, vol. 5, Article ID e1039, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Li, L. Su, N. Zhong et al., “Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells,” Autophagy, vol. 9, no. 7, pp. 1057–1068, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Mohan, S. I. Abdelwahab, B. Kamalidehghan et al., “Involvement of NF-κB and Bcl2/Bax signaling pathways in the apoptosis of MCF7 cells induced by a xanthone compound Pyranocycloartobiloxanthone A,” Phytomedicine, vol. 19, no. 11, pp. 1007–1015, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Wang and R. J. Youle, “The role of mitochondria in apoptosis,” Annual Review of Genetics, vol. 43, pp. 95–118, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Tang, Y. Zhang, R. Liang et al., “Activation of the δ-opioid receptor inhibits serum deprivation-induced apoptosis of human liver cells via the activation of PKC and the mitochondrial pathway,” International Journal of Molecular Medicine, vol. 28, no. 6, pp. 1077–1085, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H. J. Voeller, C. I. Truica, and E. P. Gelmann, “β-Catenin mutations in human prostate cancer,” Cancer Research, vol. 58, no. 12, pp. 2520–2523, 1998. View at Google Scholar · View at Scopus
  32. Q. Du and D. A. Geller, “Cross-regulation between Wnt and NF-κB signaling pathways,” Forum on Immunopathological Diseases and Therapeutics, vol. 1, no. 3, pp. 155–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Meng, Q. Lv, J. Lu et al., “Prodrug strategies for paclitaxel,” International Journal of Molecular Sciences, vol. 17, no. 5, p. 796, 2016. View at Publisher · View at Google Scholar